Yurong Ou

451 total citations
26 papers, 323 citations indexed

About

Yurong Ou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yurong Ou has authored 26 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Yurong Ou's work include Wnt/β-catenin signaling in development and cancer (5 papers), Cancer-related gene regulation (4 papers) and Epigenetics and DNA Methylation (3 papers). Yurong Ou is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (5 papers), Cancer-related gene regulation (4 papers) and Epigenetics and DNA Methylation (3 papers). Yurong Ou collaborates with scholars based in China. Yurong Ou's co-authors include Qiong Wu, Yan Yang, Jian Zhu, Huanbai Xu, Fang Su, Zhenzhong Feng, Nan Li, Qing Zhu, Qiong Zhang and Na Zhang and has published in prestigious journals such as Medicine, Oncotarget and BMC Cancer.

In The Last Decade

Yurong Ou

24 papers receiving 316 citations

Peers

Yurong Ou
Jun Meng China
Marko Kornmann Germany
Gh Rasool Bhat India
Xiaolan You China
Jian Chu China
Eva Galle Belgium
Benno Traub Germany
Doo Byung Chay South Korea
Ting‐Tai Yen United States
Jieer Ying China
Jun Meng China
Yurong Ou
Citations per year, relative to Yurong Ou Yurong Ou (= 1×) peers Jun Meng

Countries citing papers authored by Yurong Ou

Since Specialization
Citations

This map shows the geographic impact of Yurong Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yurong Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yurong Ou more than expected).

Fields of papers citing papers by Yurong Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yurong Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yurong Ou. The network helps show where Yurong Ou may publish in the future.

Co-authorship network of co-authors of Yurong Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Yurong Ou. A scholar is included among the top collaborators of Yurong Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yurong Ou. Yurong Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zheng, et al.. (2025). Integrated multi-omics analysis identifies SELENOP and PKMYT1 as immune-metabolic hub genes in breast cancer. Biochemistry and Biophysics Reports. 43. 102198–102198.
2.
Ou, Yurong, et al.. (2024). The High Expression of SLC7A11 and GPX4 are Significantly Correlated with β-Catenin in Colorectal Cancer. Cancer Management and Research. Volume 16. 1639–1648. 3 indexed citations
3.
Luo, Tianyu, et al.. (2024). Prognostic significance of RKIP, TGM2, and CMTM4 expression in oral squamous cell carcinoma. Medicine. 103(7). e37278–e37278.
4.
Zhu, Juanjuan, Rui Liu, Qin Li, et al.. (2022). The value of narrow-band imaging bronchoscopy in diagnosing central lung cancer. Frontiers in Oncology. 12. 998770–998770. 3 indexed citations
5.
Liu, Mengmeng, et al.. (2020). Alveolar soft part sarcoma of the tongue: a case report and review of the literature.. PubMed. 13(5). 1275–1282. 4 indexed citations
6.
Wang, Ansheng, Xiaojing Wang, Lu Zhang, et al.. (2019). <p>Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation</p>. OncoTargets and Therapy. Volume 12. 4261–4267. 4 indexed citations
7.
Li, Nan, Huanbai Xu, Yurong Ou, et al.. (2019). LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway. Diagnostic Pathology. 14(1). 3–3. 49 indexed citations
8.
Yang, Yan, et al.. (2019). <p>Connexin 32 downregulation is critical for chemoresistance in oxaliplatin-resistant HCC cells associated with EMT</p>. Cancer Management and Research. Volume 11. 5133–5146. 27 indexed citations
9.
Wu, Qiong, et al.. (2019). Micronodular thymoma with lymphoid stroma: report of two cases and review of literature.. PubMed. 12(9). 3625–3631. 3 indexed citations
10.
Yang, Yan, Jian Zhu, Tiantian Zhang, et al.. (2018). PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 65–65. 20 indexed citations
11.
Wang, Menghui, et al.. (2018). The correlation of KAI1, Slug and vasculogenic mimicry in the prediction of metastasis and prognosis in colorectal carcinoma.. PubMed. 11(10). 5034–5043. 1 indexed citations
12.
Yang, Yan, Na Zhang, Jian Zhu, et al.. (2017). Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma. International Journal of Oncology. 50(6). 1977–1988. 32 indexed citations
13.
Su, Fang, Jun Zhao, Shukui Qin, et al.. (2017). Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma. Oncotarget. 8(14). 23277–23288. 38 indexed citations
14.
Yang, Yan, Yumei Li, Rui Wang, et al.. (2016). Role of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma. Oncology Letters. 12(1). 429–436. 15 indexed citations
15.
Ou, Yurong, et al.. (2015). [T Cell Factor 4, beta-catenin and SFRP1 Expression of Wnt Signaling Pathway in Colorectal Carcinoma and the Prognosis].. PubMed. 32(4). 854–61. 2 indexed citations
16.
Zhang, Yanling, Yurong Ou, Donghong Yu, et al.. (2015). Clinicopathological study of centrally necrotizing carcinoma of the breast. BMC Cancer. 15(1). 282–282. 9 indexed citations
17.
18.
Ou, Yurong, et al.. (2015). [Expression of Tcf-4, MMP7 and Survivin in Colorectal Cancer and Its Clinical Significance].. PubMed. 46(4). 554–9. 1 indexed citations
19.
Ding, Ling, et al.. (2015). Grape seed proanthocyanidins prevent DOCA-salt hypertension-induced renal injury and its mechanisms in rats. Food & Function. 6(7). 2179–2186. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Meng Breakdown of academic impact, for papers by Marko Kornmann Breakdown of academic impact, for papers by Gh Rasool Bhat Breakdown of academic impact, for papers by Xiaolan You Breakdown of academic impact, for papers by Jian Chu Breakdown of academic impact, for papers by Eva Galle Breakdown of academic impact, for papers by Benno Traub Breakdown of academic impact, for papers by Doo Byung Chay Breakdown of academic impact, for papers by Ting‐Tai Yen Breakdown of academic impact, for papers by Jieer Ying
Rankless by CCL
2026